Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2016 April;107(2) > Minerva Medica 2016 April;107(2):101-7

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

REVIEWS  


Minerva Medica 2016 April;107(2):101-7

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Long non-coding RNA-LET can indicate metastasis and a poor prognosis: a meta-analysis

Fang T. LIU 1, Pei Q. ZHU 1, Yang X. OU 1, Quan S. LIN 2, Cheng QIU 1, Hong L. LUO 1

1 Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China; 2 Department of Respiratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China


PDF  


INTRODUCTION: Recent studies have reported that long non-coding RNA low expression in tumor (lncRNA-LET) was down-regulated in several cancers. The current meta-analysis aims to determine whether lncRNA-LET can be used as a potential biomarker for metastasis and prognosis.
EVIDENCE ACQUISITION: We collected all relevant papers by searching multiple electronic databases (PubMed, EMBASE, Google Scholar, CNKI, Wanfang Database) and explored the association between the expression levels of lncRNA-LET and lymph node metastasis (LNM), distant metastasis (DM) and overall survival (OS).
EVIDENCE SYNTHESIS: A total of 383 patients from four studies were finally included. The meta-analysis results showed that LNM occurred more frequently in patients from the lncRNA-LET low expression group than in patients from the lncRNA-LET overexpression group (OR=4.56, 95% CI 2.92-7.12, P<0.00001), and a similar result was observed between lncRNA-LET expression and DM (OR=4.77, 95% CI 2.29-9.94, P<0.0001). Additionally, we found that patients with low expression of lncRNA-LET had a poorer OS than those with lncRNA-LET overexpression (HR=2.39, 95% CI 1.57-3.21, P=0.000).
CONCLUSIONS: lncRNA-LET may serve as a common molecular marker for metastasis and prognosis in human cancers.

top of page

Publication History

Cite this article as

Liu FT, Zhu PQ, Ou YX, Lin QS, Qiu C, Luo HL. Long non-coding RNA-LET can indicate metastasis and a poor prognosis: a meta-analysis. Minerva Med 2016 April;107(2):101-7. 

Corresponding author e-mail

517295653@qq.com